𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma

✍ Scribed by David R. Minor; Dana Monroe; Lisa A. Damico; Gloria Meng; Uma Suryadevara; Laurence Elias


Book ID
110398188
Publisher
Springer US
Year
2002
Tongue
English
Weight
60 KB
Volume
20
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A pilot study of thalidomide in patients
✍ Danai D. Daliani; Christos N. Papandreou; Peter F. Thall; Xuemei Wang; Cherie Pe πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## Background: The highly vascular nature of renal cell carcinoma (rcc) suggests that angiogenesis inhibition may be therapeutic for patients with this disease. thalidomide inhibits basic fibroblast growth factor and vascular endothelial growth factor (vegf)-induced angiogenesis. ## Methods: In a